NCT04741997 2026-03-02
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
H. Lee Moffitt Cancer Center and Research Institute
Radiopharm Theranostics, Ltd
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Juncell Therapeutics
University of Virginia
Dana-Farber Cancer Institute
University of Pittsburgh
CivaTech Oncology
Presage Biosciences